PDCD1 and neoplasm: We used CRISPR/Cas9 to remove two genes encoding endogenous TCR, TCRα and TCRβ, and PDCD1 encoding PD-1 in T cells, and inserted a synthetic cancer-specific TCR gene (NY-ESO-1) into T cells to identify tumor cells.